Tempest Therapeutics (TPST) Total Debt (2017 - 2025)
Tempest Therapeutics (TPST) posted Total Debt of $8.4 million for Q1 2025, down 34.22% sequentially from $12.8 million in Q4 2024, and down 20.83% YoY from $10.6 million in Q1 2024.
Tempest Therapeutics (TPST) Total Debt (2017 - 2025) Analysis & Trends
Tempest Therapeutics has reported Total Debt for 9 years, with the latest figure at $8.4 million in Q1 2025.
- Quarterly Total Debt fell 20.83% year-over-year to $8.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $8.4 million (down 20.83% YoY) and the FY2024 annual result came in at $12.8 million, up 20.9% from the prior year.
- Total Debt eased to $8.4 million in Q1 2025 per TPST's latest filing, from $12.8 million in the prior quarter.
- Over five years, Total Debt peaked at $17.0 million in Q3 2024 and troughed at $8.4 million in Q1 2025.
- A 5-year average of $12.9 million and a median of $12.8 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2021 and 2023: Total Debt jumped 6659.01% in 2021, then plunged 31.65% in 2023.
- Over 5 years, Total Debt stood at $15.1 million in 2021, then plunged by 31.18% to $10.4 million in 2022, then climbed by 1.72% to $10.5 million in 2023, then rose by 20.9% to $12.8 million in 2024, then sank by 34.22% to $8.4 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $8.4 million, $12.8 million, and $17.0 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.34 Bn |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 8.39 Mn |
| Dec 31, 2024 | 12.75 Mn |
| Sep 30, 2024 | 17.00 Mn |
| Jun 30, 2024 | 10.65 Mn |
| Mar 31, 2024 | 10.60 Mn |
| Dec 31, 2023 | 10.55 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 10.46 Mn |
| Mar 31, 2023 | 10.42 Mn |
| Dec 31, 2022 | 10.37 Mn |
| Sep 30, 2022 | 15.34 Mn |
| Jun 30, 2022 | 15.30 Mn |
| Mar 31, 2022 | 15.13 Mn |
| Dec 31, 2021 | 15.07 Mn |
| Sep 30, 2021 | 15.01 Mn |
| Jun 30, 2021 | 14.92 Mn |
| Mar 31, 2021 | 15.30 Mn |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | 222,000.00 |
| Jun 30, 2020 | 375,000.00 |